Unknown PHASE2 INTERVENTIONAL 2-arm NCT02027363

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

Maintenance Treatment With Capecitabine Versus Observation After First Line Chemotherapy in Patients With Metastatic Colorectal Cancer: a Randomized Phase II Study

Sponsor: Sun Yat-sen University

Conditions Colorectal Neoplasms Neoplasms Metastasis

Interventions Capecitabine Observation

Updated 5 times since 2017 Last updated: Jan 2, 2014 Started: Jan 31, 2010 Primary completion: Dec 31, 2013 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02027363, this PHASE2 trial focuses on Colorectal Neoplasms and Neoplasms Metastasis and remains ongoing. Sponsored by Sun Yat-sen University, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China